EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
EDAP (Nasdaq: EDAP) will release first quarter 2026 financial results before market open on May 7, 2026.
Rhea-AI Summary
EDAP (Nasdaq: EDAP) will release first quarter 2026 financial results before market open on May 7, 2026. A conference call and webcast with CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch is scheduled for 8:30 a.m. EDT the same day.
Investors can join via domestic and international dial-in numbers using passcode EDAP, or access the live webcast through the provided registration link.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EDAP
On Apr 16, the day this news came out, EDAP closed 1.99% above the previous close.
Data tracked by StockTitan Argus for the Apr 16 session.
Key Figures
- Q1 2026 period end
- March 31, 2026
- Quarter to be reported
- Earnings release date
- May 7, 2026
- Q1 2026 financial results announcement before market open
- Conference call time
- 8:30 a.m. EDT
- Q1 2026 results call on May 7, 2026
- Domestic dial-in
- 1-800-343-4136
- US access number for Q1 2026 call
- International dial-in
- 1-203-518-9843
- International access number for Q1 2026 call
Previous Earnings date Reports
-
Announced Q4 and FY 2025 results release date and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
, April 16, 2026 (GLOBE NEWSWIRE) -- EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
Company to host conference call and webcast on Thursday, May 7 at 8:30 a.m. EDT
AUSTIN, Texas, April 16, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2026, before market open on Thursday, May 7, 2026.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Thursday, May 7th
Time: 8:30 a.m. EDT
Domestic: 1-800-343-4136
International: 1-203-518-9843
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1759064&tp_key=77ec2128dc
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes, and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics, and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and the United States as a leading prostate focal therapy controlled by urologists, with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.
Investor Contacts
Investor Relations
EDAP TMS SA
investor.relations@focalone.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.